Adverse Neonatal Outcomes Among Children Born to Mothers Eating Disorders: A Register-Based Cohort Study

Hannah Chatwin1, Katrine Holde1, Natalie C Momen2

  • 1National Centre for Register-Based Research (NCRR), Aarhus University, Aarhus, Denmark.

Insights

Maternal eating disorders (EDs) increase the risk of adverse neonatal outcomes, particularly when the diagnosis is recent. Enhanced prenatal monitoring is crucial for mothers with EDs to improve infant health.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Medicine
  • Psychiatry

Background:

  • Maternal eating disorders (EDs) encompass conditions like anorexia nervosa (AN), bulimia nervosa (BN), and EDs not otherwise specified (EDNOS).
  • The impact of maternal EDs on neonatal outcomes requires further investigation to inform clinical practice and public health strategies.

Purpose of the Study:

  • To examine the association between maternal EDs (AN, BN, EDNOS) and adverse neonatal outcomes.
  • To compare risks associated with recent (≤2 years before conception and during pregnancy) versus past (>2 years before conception) ED diagnoses.

Main Methods:

  • Population-based cohort study utilizing Danish national registers.
  • Inclusion of 1,517,839 singletons born between 1991 and 2015.
  • Multinomial logistic regression analysis to estimate relative risk ratios (RRRs) for neonatal outcomes.

Main Results:

  • Both recent and past AN were linked to increased risks of low birthweight, small-for-gestational age (SGA), and preterm birth, with higher risks for recent AN.
  • Recent BN was associated with a higher risk of low Apgar score.
  • Recent EDNOS showed an increased risk of SGA.

Conclusions:

  • Maternal EDs are associated with an elevated risk of specific adverse neonatal outcomes.
  • The risk is more pronounced with recent ED diagnoses compared to past diagnoses.
  • Improved prevention of maternal EDs and enhanced prenatal monitoring are essential for mitigating adverse neonatal outcomes.
Abstract

Related Concept Videos

Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
43
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
46
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
48
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
866
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
40